| Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Journal Article
- Language: English
- [Med Biol Eng Comput] 2022 Oct; Vol. 60 (10), pp. 2877-2897. <i>Date of Electronic Publication: </i>2022 Aug 10.
- MeSH Terms: Colorectal Neoplasms* / drug therapy ; Colorectal Neoplasms* / genetics ; Machine Learning* ; Gene Ontology ; Humans
- References: Marisa L, de Reyniès A, Duval A, Selves J et al (2013) Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med 10(5):e1001453. (PMID: 23700391366025110.1371/journal.pmed.1001453) ; Gröne J, Lenze D, Jurinovic V, Hummel M et al (2011) Molecular profiles and clinical outcome of stage UICC II colon cancer patients. Int J Colorectal Dis 26(7):847–858. (PMID: 2146519010.1007/s00384-011-1176-x) ; Berlin JW, Gore RM, Yaghmai V, Newmark GM, Miller FH (2000) Staging of colorectal cancer. Semin Roentgenol XXXV(4):370–384. (PMID: 10.1053/sroe.2000.17759) ; Adachi T, Hinoi T, Sasaki Y, Hiroaki N, Saito Y, Miguchi M, Shimomura M, Ohdan H (2013) Colonoscopy as a tool for evaluating colorectal tumor development in a mouse model. Int J Colorectal Dis. https://doi.org/10.1007/s00384-013-1791-9. (PMID: 10.1007/s00384-013-1791-924212401) ; Levin B, Lieberman DA, McFarland B et al (2008) Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on colorectal cancer, and the American College of Radiology. Gastroenterology 134(5):1570–1595. (PMID: 1838478510.1053/j.gastro.2008.02.002) ; Klessen C, Rogalla P, Taupitz M (2007) Local staging of rectal cancer: the current role >of MRI. Eur Radiol 17:379–389. (PMID: 1700899010.1007/s00330-006-0388-x) ; Bauer KM, Hummon AB, Buechler S (2012) Right-side and left-side colon cancer follow different pathways to relapse. Mol Carcinog 51(5):411–421. (PMID: 2165657610.1002/mc.20804) ; Lee MS, Menter DG, Kopetz S (2017) Right versus left colon cancer biology: integrating the consensus molecular subtypes. J Natl Compr Canc Netw 15:411–419. (PMID: 2827503910.6004/jnccn.2017.0038) ; Demurtas L, Puzzoni M, Giampieri R et al (2017) The role of primary tumor sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab. Br J Cancer 117:315–321. (PMID: 28632725553749410.1038/bjc.2017.178) ; Cannon E, Buechler S (2019) Colon cancer tumor location defined by gene expression may disagree with anatomic tumor location. Clin Colorectal Cancer 18(2):149–158. (PMID: 3085332610.1016/j.clcc.2019.02.002) ; Manavalan R, Priya S (2021) Genetic interactions effects for cancer disease identification using computational models: a review. Med Biol Eng Comput 59:733–758. (PMID: 3383999810.1007/s11517-021-02343-9) ; Maurya NS, Kushwaha S, Chawade A, Mani A (2021) Transcriptome profiling by combined machine learning and statistical R analysis identifies TMEM236 as a potential novel diagnostic biomarker for colorectal cancer. Sci Rep 11(1):1–11. (PMID: 10.1038/s41598-021-92692-0) ; Kourou K, Exarchos TP, Exarchos KP, Karamouzis MV, Fotiadis DI (2015) Machine learning applications in cancer prognosis and prediction. Comput Struct Biotechnol J 13:8–17. (PMID: 2575069610.1016/j.csbj.2014.11.005) ; Gupta, P., Chiang, S. F., Sahoo, P. K., Mohapatra, S. K., You, J. F., Onthoni, D. D., Hung, H. Y., Chiang, J. M., Huang Y., Tsai, W. S. (2019). Prediction of colon cancer stages and survival period with machine learning approach. Cancers, 11(12). ; Hatzidaki E, Iliopoulos A, Papasotiriou I (2021) A novel method for colorectal cancer screening based on circulating tumor cells and machine learning. Entropy 23(10):1248. (PMID: 34681972853457010.3390/e23101248) ; Zhao D, Liu H, Zheng Y, He Y, Lu D, Lyu C (2019) A reliable method for colorectal cancer prediction based on feature selection and support vector machine. Med Biol Eng Comput 57(4):901–912. (PMID: 3047881110.1007/s11517-018-1930-0) ; Loupakis F, Yang D, Yau L et al (2015). Primary tumor location as a prognostic factor in metastatic colorectal cancer. J Natl Cancer Inst 107(3). ; Petrelli F, Tomasello G, Borgonovo K et al (2017) Prognostic survival associated with left-sided vs right-sided colon cancer: a systematic review and meta-analysis. JAMA Oncol 3(2):211–219. (PMID: 2778755010.1001/jamaoncol.2016.4227) ; Hamzeh O, Alkhateeb A, Zheng J, Kandalam S, Rueda L (2020) Prediction of tumor location in prostate cancer tissue using a machine learning system on gene expression data. BMC Bioinform 21(2):1–10. ; Shimada Y, Kameyama H, Nagahashi M et al (2017) Comprehensive genomic sequencing detects important genetic differences between right-sided and left-sided colorectal cancer. Oncotarget 8(55):93567–93579. (PMID: 29212173570681910.18632/oncotarget.20510) ; Jiang Y, Yan X, Liu K et al (2020) Discovering the molecular differences between right-and left-sided colon cancer using machine learning methods. BMC Cancer 20(1):1–11. (PMID: 10.1186/s12885-019-6169-0) ; Peng S, Xu Q, Ling XB, Peng X, Du W, Chen L (2003) Molecular classification of cancer types from microarray data using the combination of genetic algorithms and support vector machines. FEBS Lett 555:358–362. (PMID: 1464444210.1016/S0014-5793(03)01275-4) ; Lin TC, Liu RS, Chen CY, Chao YT, Chen SY (2006) Pattern classification in DNA microarray data of multiple tumor types. Pattern Recognit 39:2426–2438. (PMID: 10.1016/j.patcog.2006.01.004) ; Ventura-Molina E, Alarcón-Paredes A, Aldape-Pérez M, Yáñez-Márquez C, Adolfo Alonso G (2019) Gene selection for enhanced classification on microarray data using a weighted k-NN based algorithm. Intell Data Anal 23(1):241–253. (PMID: 10.3233/IDA-173720) ; Dong M, Kothari R (2003) Feature subset selection using a new definition of classifiability. Pattern Recogn Lett 24(9–10):1215–1225. (PMID: 10.1016/S0167-8655(02)00303-3) ; Dietterich TG (1997) Machine-learning research—four current directions. AI Mag 18:97–136. ; Kohavi R, John G (1997) Wrappers for feature selection. Artif Intell 97:273–324. (PMID: 10.1016/S0004-3702(97)00043-X) ; Wettschereck D, Aha DW, Mohri T (1997) A review and empirical evaluation of feature weighting methods for a class of lazy learning algorithms. Artif Intell Rev 11:273–314. (PMID: 10.1023/A:1006593614256) ; Franke TM, Ho T (2012) Christie AC the chi-square test: often used and more often misinterpreted. Am J Eval 33(3):448–558. (PMID: 10.1177/1098214011426594) ; Al Snousy MB, El-Deeb HM, Badran K, Al Khlil IA (2011) Suite of decision tree-based classification algorithms on cancer gene expression data. Egypt Inform J 12:73–82. (PMID: 10.1016/j.eij.2011.04.003) ; Subramanian A, Tamayo P, Mootha VK et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. PNAS 102(43):15545–15550. (PMID: 16199517123989610.1073/pnas.0506580102) ; Mootha VK, Lindgren CM, Eriksson KF et al (2003) PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat 34(3):267–273. ; Fonti V, Belitser E (2017) Feature selection using lasso. VU Amsterdam Research Paper in Business Analytics 30:1–25. ; Schapire RE, Freund Y, Bartlett P, Lee WS (1998) Boosting the margin: a new explanation for the effectiveness of voting methods. Ann Stat 26(5):1651–1686. ; Dietterich TG (2000) An experimental comparison of three methods for constructing ensembles of decision trees: bagging, boosting, and randomization. Mach Learn 40(2):139–157. (PMID: 10.1023/A:1007607513941) ; Schwenk H, Bengio Y (2000) Boosting neural networks. Neural Comput 12(8):1869–1887. (PMID: 1095324210.1162/089976600300015178) ; Ratsch G, Onoda T, Muller KR (2001) Soft margins for AdaBoost Machine learning 42(3):287–320. (PMID: 10.1023/A:1007618119488) ; Feng PM, Ding H, Chen W, Lin H (2013) Naive Bayes classifier with feature selection to identify phage virion proteins. Comput Math Methods Med 2013:530696. (PMID: 237621873671239) ; Widodo A, Yang BS (2007) Support vector machine in machine condition monitoring and fault diagnosis. MSSP 21(6):2560–2574. ; Kırmacı B, Ogul H (2015) Evaluating text features for lyrics-based songwriter prediction. INES 405–409. ; Mishra NK, Chang J, Zhao PX (2014) Prediction of membrane transport proteins and their substrate specificities using primary sequence information. PLoS ONE 9(6):e100278. (PMID: 24968309407267110.1371/journal.pone.0100278) ; Mi, H., Dong, Q., Muruganujan, A., Gaudet, P., Lewis, S., & Thomas, P. D. (2010). PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium. Nucleic acids research, 38(suppl_1), D204-D210. ; Warde-Farley D, Donaldson SL, Comes O et al (2010) The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 38(2):W214–W220. (PMID: 20576703289618610.1093/nar/gkq537) ; Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498–2504. (PMID: 1459765840376910.1101/gr.1239303) ; Bader GD, Hogue CW (2003) An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinform 4(1):1–27. (PMID: 10.1186/1471-2105-4-2) ; Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY (2014) cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol 8(4):1–7. ; Cotto KC, Wagner AH, Feng YY et al (2018) DGIdb 30: a redesign and expansion of the drug–gene interaction database. Nucleic Acids Res 46(D1):D1068–D1073. (PMID: 2915600110.1093/nar/gkx1143) ; Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, Yefanov A, Lee H, Zhang N, Robertson CL, Serova N, Davis S, Soboleva A (2012) NCBI GEO: archive for functional genomics data sets—update”. Nucleic Acids Res 41(D1):D991–D995. (PMID: 23193258353108410.1093/nar/gks1193) ; Jorissen RN, Gibbs P, Christie M, Prakash S et al (2009) Metastasis-associated gene expression changes predict poor outcomes in patients with Dukes stage B and C colorectal cancer. Clin Cancer Res 15(24):7642–7651. (PMID: 19996206292075010.1158/1078-0432.CCR-09-1431) ; Laibe S, Lagarde A, Ferrari A, Monges G et al (2012) A seven-gene signature aggregates a subgroup of stage II colon cancers with stage III. OMICS 16(10):560–565. (PMID: 2291748010.1089/omi.2012.0039) ; Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP (2003) Exploration, normalization, and summaries of high-density oligonucleotide array probe level data. Biostatistics 4(2):249–264. (PMID: 1292552010.1093/biostatistics/4.2.249) ; Ratto C, Sofo L, Ippoliti M, Merico M, Doglietto GB, Crucitti F (1998) Prognostic factors in colorectal cancer DICRAG 41(8):1033–1049. (PMID: 9715162) ; Sorbye H, Pfeiffer P, Cavalli-Björkman N, Qvortrup C, Holsen MH, Wentzel-Larsen T, Glimelius B (2009) Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients. Cancer 115(20):4679–4687. (PMID: 1956277710.1002/cncr.24527) ; Christensen TD, Spindler KLG, Palshof JA, Nielsen DL (2016) Systematic review: brain metastases from colorectal cancer—incidence and patient characteristics. BMC Cancer 16(1):1–14. (PMID: 10.1186/s12885-016-2290-5) ; Brell JM, Bruno DS, Lewis SA, Thornton JD (2017) Influence of patient characteristics on provider surveillance for colorectal cancer. Am J Clin Oncol. 35(15): https://doi.org/10.1200/JCO.2017.35.15_suppl.10071. ; Liang L, Zeng JH, Qin XG, Chen JO, Luo DZ, Chen G (2018) Distinguishable prognostic signatures of left- and right-sided colon cancer: a study based on sequencing data cell Physiol. Biochem 48(2):475–490. ; Li P, Xiao Z, Braciak TA, Ou Q, Chen G, Oduncu FS (2017) A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients. PLoS ONE 12(3):e0172799. (PMID: 28253296533384010.1371/journal.pone.0172799) ; Tsai YJ, Huang SC, Lin HH et al (2018) Differences in gene mutations according to gender among patients with colorectal cancer. J Surg Oncol 16(1):1–5. ; Tatangelo F, Di Mauro A, Scognamiglio G, Aquino G, Lettiero A, Delrio P, Avallone A, Cantile M, Botti G (2018) Posterior HOX genes and HOTAIR expression in the right sided and left sided colon cancer pathogenesis. J Transl Med 16(1):1–10. (PMID: 10.1186/s12967-018-1725-y) ; Yuan Y, Chen J, Wang J, Xu M, Zhang Y, Sun P, Liang L (2020) Development and clinical validation of a novel 4-gene prognostic signature predicting survival in colorectal cancer. Front Oncol 10:595. (PMID: 32509568725117910.3389/fonc.2020.00595) ; Ji M, Feng Q, He G, Yang L, Tang W, Lao X, Zhu D, Lin Q, Xu P, Wei Y, Xu J (2016) Silencing homeobox C6 inhibits colorectal cancer cell proliferation. Oncotarget 7(20):29216–29227. (PMID: 27081081504539110.18632/oncotarget.8703) ; Alajez NM (2016) Large-scale analysis of gene expression data reveals a novel gene expression signature associated with colorectal cancer distant recurrence. PLoS ONE 11(12):e0167455. (PMID: 27935967514789810.1371/journal.pone.0167455) ; Jung C, Kim RS, Zhang H, Lee SJ, Sheng H, Loehrer PJ, Gardner TA, Jeng MH, Kao C (2005) HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation. Br J Cancer 92(12):2233–2239. (PMID: 15928669236182810.1038/sj.bjc.6602631) ; Xie B, Bai B, Xu Y, Liu Y, Lv Y, Gao X, Wu F, Fang Z, Lou Y, Pan H, Han W (2019) Tumor-suppressive function and mechanism of HOXB13 in right-sided colon cancer. Signal Transduct Target Ther 4(1):1–14. (PMID: 10.1038/s41392-018-0034-5) ; Ghoshal K, Motiwala T, Claus R, Yan P, Kutay H, Datta J, Majumder S, Bai S, Majumder A, Huang T, Plass C, Jacob ST (2010) HOXB13, a target of DNMT3B, is methylated at an upstream CpG island, and functions as a tumor suppressor in primary colorectal tumors. PLoS ONE 5(4):e10338. (PMID: 20454457286159910.1371/journal.pone.0010338) ; Sewda K, Coppola D, Enkemann S, Yue B, Kim J, Lopez AS, Wojtkowiak JW, Stark VE, Morse B, Shibata D, Vignesh S, Morse DL (2016) Cell-surface markers for colon adenoma and adenocarcinoma. Oncotarget 7(14):17773–17789. (PMID: 26894861495124910.18632/oncotarget.7402) ; Krattinger R, Boström A, Schiöth HB, Thasler WE, Mwinyi J, Kullak-Ublick GA (2016) microRNA-192 Suppresses the expression of the Farnesoid X receptor. Am J Physiol Gastrointest Liver Physiol 310(11):G1044–G1051. (PMID: 2707961410.1152/ajpgi.00297.2015) ; Bailey AM, Zhan L, Maru D, Shureiqi I, Pickering CR, Kiriakova G, Izzo J, He N, Wei C, Baladandayuthapani V, Liang H, Kopetz S, Powis G, Guo GL (2014) FXR silencing in human colon cancer by DNA methylation and KRAS signaling. Am J Physiol Gastrointest Liver Physiol 306(1):G48–G58. (PMID: 2417703110.1152/ajpgi.00234.2013) ; Lax S, Schauer G, Prein K, Kapitan M, Silbert D, Berghold A, Berger A, Trauner M (2012) Expression of the nuclear bile acid receptor/Farnesoid X receptor is reduced in human colon carcinoma compared to nonneoplastic mucosa independent from site and may be associated with adverse prognosis. Int J Ca 130(10):2232–2239. (PMID: 10.1002/ijc.26293) ; Kim JH, Kim KJ, Rhee YY, Bae JM, Cho NY, Lee HS, Kang GH (2015) Gastric-type expression signature in serrated pathway-associated colorectal tumors. Hum Pathol 46(5):643–656. (PMID: 2570480510.1016/j.humpath.2015.01.003) ; Caruso M, Moore J, Goodall GJ, Thomas M, Phillis S, Tyskin A, Cheetham G, Lerda N, Takahashi H, Ruszkiewicz A (2009) Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis. Virchows Arch 454(3):291–302. (PMID: 1917229110.1007/s00428-009-0731-0) ; Murakami T, Sakamoto N, Nagahara A (2019) Clinicopathological features, diagnosis, and treatment of sessile serrated adenoma/polyp with dysplasia/carcinoma. J Gastroenterol Hepatol 34(10):1685–1695. (PMID: 3115830210.1111/jgh.14752) ; Menyhart O, Kakisaka T, Pongor LS, Uetake H, Goel A, Győrffy B (2019) Uncovering potential therapeutic targets in colorectal cancer by deciphering mutational status and expression of druggable oncogenes. Cancers 11(7):983. (PMID: 667919810.3390/cancers11070983) ; De Vriendt V, De Roock W, Di Narzo AF, Tian S, Biesmans B, Jacobs B, Budinska E, Sagaert E, Rossi S, D’Ario G, Delorenzi M, Simon I, Vecchione L, Tejpar S (2013) DUSP 4 expression identifies a subset of colorectal cancer tumors that differ in MAPK activation, regardless of the genotype. Biomarkers 18(6):516–524. (PMID: 2387591210.3109/1354750X.2013.819038) ; Park SM, Hwang CY, Cho SH, Lee D, Gong JR, Lee S, Nam S, Cho KH (2019) Systems analysis identifies potential target genes to overcome cetuximab resistance in colorectal cancer cells. FEBS J 286(7):1305–1318. (PMID: 3071983410.1111/febs.14773) ; Kang X, Li M, Zhu H et al (2017) DUSP4 promotes doxorubicin resistance in gastric cancer through epithelial-mesenchymal transition. Oncotarget 8(55):94028–94039. (PMID: 29212207570685310.18632/oncotarget.21522) ; Gröschl B, Bettstetter M, Giedl C et al (2013) Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation. Int J Cancer 132(7):1537–1546. (PMID: 2296587310.1002/ijc.27834) ; Sim J, Yi K, Kim H, Ahn H, Chung Y, Rehman A, Jang SM, Lee KH, Jang K, Paik SS (2015) Immunohistochemical expression of dual-specificity protein phosphatase 4 in patients with colorectal adenocarcinoma. Gastroenterol Res Pract 2015:283764. (PMID: 25688264432079410.1155/2015/283764) ; Cagnol S, Rivard N (2013) Oncogenic KRAS and BRAF activation of the MEK/ERK signaling pathway promotes expression of dual-specificity phosphatase 4 (DUSP4/MKP2) resulting in nuclear ERK1/2 inhibition. Oncogene 32(5):564–576. (PMID: 2243021510.1038/onc.2012.88) ; Strubberg AM, Paniagua DAV, Zhao T, Dublin L, Pritchard T, Bayguinov PO, Fitzpatrick JAJ, Madison BB (2018) The zinc finger transcription factor PLAGL2 enhances stem cell fate and activates expression of ASCL2 in intestinal epithelial cells. Stem Cell Reports 11(2):410–424. (PMID: 30017821609269510.1016/j.stemcr.2018.06.009) ; Wu L, Zhou Z, Han S, Chen J, Liu Z, Zhang X, Yuan W, Ji J, Shu X (2020) PLAGL2 promotes epithelial-mesenchymal transition and mediates colorectal cancer metastasis via β-catenin-dependent regulation of ZEB1. Br J Cancer 122(4):578–589. (PMID: 3182723810.1038/s41416-019-0679-z) ; Zhou J, Liu H, Zhang L, Liu X, Zhang C, Wang Y, He Q, Zhang Y, Li Y, Chen Q, Zhang L, Wang K, Bu Y, Lei Y (2018) DJ-1 promotes colorectal cancer progression through activating PLAGL2/Wnt/BMP4 axis. Cell Death Dis 9(9):1–12. ; Su C, Li D, Li N, Du Y, Yang C, Bai Y, Lin C, Li X, Zhang Y (2018) Studying the mechanism of PLAGL2 overexpression and its carcinogenic characteristics based on 3’-untranslated region in colorectal cancer. Int J Oncol 52(5):1479–1490. (PMID: 295127635873895) ; Li D, Lin C, Li N, Du Y, Yang C, Bai Y, Feng Z, Su C, Wu R, Song S, Yan P, Chen M, Jain A, Huang L, Zhang Y, Li X (2019) PLAGL2 and POFUT1 are regulated by an evolutionarily conserved bidirectional promoter and are collaboratively involved in colorectal cancer by maintaining stemness. EBioMedicine 45:124–138. (PMID: 31279780664233410.1016/j.ebiom.2019.06.051) ; Li N, Li D, Du Y, Su C, Yang C, Lin C, Li X, Hu G (2019) Overexpressed PLAGL2 transcriptionally activates Wnt6 and promotes cancer development in colorectal cancer. Oncol Rep 41(2):875–884. (PMID: 30535429) ; Liu X, Chen X, Zeng K, Xu M, He B, Pan Y, Sun H, Pan B, Xu X, Xu T, Hu X, Wang S (2018) DNA-methylation-mediated silencing of miR-486–5p promotes colorectal cancer proliferation and migration through activation of PLAGL2/IGF2/β-catenin signal pathways cell death. Dis 9(10):1–17. ; Yang L, Li L, Ma J, Yang S, Zou C, Yu X (2019) miRNA and mRNA integration network construction reveals novel key regulators in left-sided and right-sided colon adenocarcinoma. Biomed Res Int 2019:7149296. (PMID: 310735306470432) ; Lv Y, Xie B, Bai B, Shan L, Zheng W, Huang X, Zhu H (2019) Weighted gene coexpression analysis indicates that PLAGL2 and POFUT1 are related to the differential features of right sided and left sided colorectal cancer. Oncol Rep 42(6):2473–2485. (PMID: 316382466826322) ; Zhou Z, Wu L, Liu Z, Zhang X, Han S, Zhao N, Bao H, Yuan W, Chen J, Ji J, Shu X (2020) MicroRNA-214-3p Targets the PLAGL2-MYH9 axis to suppress tumor proliferation and metastasis in human colorectal cancer. Aging 12(10):9633–9657. (PMID: 32413870728895810.18632/aging.103233) ; Giordano G, Parcesepe P, D’Andrea MR, Coppola L, Di Raimo T, Remo A, Manfrin E, Fiorini C, Scarpa A, Amoreo CA, Conciatori F, Milella M, Caruso FP, Cerulo L, Porras A, Pancione M (2019) JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, Locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancer. J Exp Clin Cancer Res 38(1):1–11. (PMID: 10.1186/s13046-018-1018-6) ; Birkenkamp-Demtroder K, Mansilla F, Sørensen FB, Kruhøffer M, Cabezón T, Christensen LL, Aaltonen LA, Verspaget HW, Ørntoft TF (2007) Phosphoprotein keratin 23 accumulates in MSS but not MSI colon cancers in vivo and impacts viability and proliferation in vitro. Mol Oncol 1(2):181–195. (PMID: 19383294554389310.1016/j.molonc.2007.05.005) ; Birkenkamp-Demtröder K, Hahn SA, Mansilla F, Thorsen K, Maghnouj A, Christensen R, Øster B, Ørntoft TF (2013) Keratin23 (KRT23) Knockdown decreases proliferation and affects the DNA damage response of colon cancer cells. PLoS ONE 8(9):e73593. (PMID: 24039993376779810.1371/journal.pone.0073593) ; Zhang N, Zhang R, Zou K, Yu W, Guo W, Gao Y, Li J, Li M, Tai Y, Huang W, Song C, Deng W, Cui X (2017) Keratin 23 promotes telomerase reverse transcriptase expression and human colorectal cancer growth. Cell Death Dis 8(7):e2961. (PMID: 28749462555088010.1038/cddis.2017.339) ; Zhao ZW, Fan XX, Yang LL, Song JJ, Fang SJ, Tu JF, Chen MJ, Zheng LY, Wu FZ, Zhang DK, Ying XH, Ji JS (2019) The identification of a common different gene expression signature in patients with colorectal cancer. Math Biosci Eng 16(4):2942–2958. (PMID: 3113724410.3934/mbe.2019145) ; Gao X, Yang J, Gao X et al (2020) Identification of genes related to clinicopathological characteristics and prognosis of patients with colorectal cancer. DNA Cell Biol 39(4):690–699. (PMID: 3202718110.1089/dna.2019.5088) ; Broussard EK, Kim R, Wiley JC, Marquez JP, Annis JE, Pritchard D, Disis ML (2013) Identification of putative immunologic targets for colon cancer prevention based on conserved gene upregulation from preinvasive to malignant lesions. Cancer Prev Res 6(7):666–674. (PMID: 10.1158/1940-6207.CAPR-12-0484) ; Astrosini C, Roeefzaad C, Dai YY, Dieckgraefe BK, Jöns T, Kemmner W (2008) REG1A expression is a prognostic marker in colorectal cancer and associated with peritoneal carcinomatosis. Int J Cancer 123(2):409–413. (PMID: 1845217210.1002/ijc.23466) ; Lee WS, Seo G, Shin HJ, Yun SH, Yun H, Choi N, Lee J, Son D, Cho J, Kim J, Cho YB, Chun HK, Lee WY, Lee WS et al (2008) Identification of differentially expressed genes in microsatellite stable HNPCC and sporadic colon cancer. J Surg Res. 144(1):29–35. https://doi.org/10.1016/j.jss.2007.02.005. (PMID: 10.1016/j.jss.2007.02.00517950328) ; Macadam RC, Sarela AI, Farmery SM, Robinson PA, Markham AF, Guillou PJ (2000) Death from early colorectal cancer is predicted by the presence of transcripts of the REG gene family. Br J Cancer 83(2):188–195. (PMID: 10901369236349410.1054/bjoc.2000.1227) ; Ak S, Tunca B, Yilmazlar T, Tezcan G, Cecener G, Egeli U, Ozturk E, Yerci O, Ertürk E, Zorluoglu A (2013) Microsatellite instability status affects gene expression profiles in early onset colorectal cancer patients. J Surg Res 185(2):626–637. (PMID: 2399285510.1016/j.jss.2013.07.014) ; Wang Y, Liu X, Liu J, Zhang T (2019) Knockdown of REG Iα enhances the sensitivity to 5-fluorouracil of colorectal cancer cells via cyclin D1/CDK4 pathway and BAX/BCL-2 pathways. Cancer Biother Radiopharm 34(6):362–370. (PMID: 3097327110.1089/cbr.2018.2746) ; Sohier P, Sanson R, Leduc M, Audebourg A, Broussard C, Salnot V, Just PA, Pasmant E, Mayeux P, Guillonneau F, Romagnolo B, Perret C, Terris B (2020) Proteome analysis of formalin-fixed paraffin-embedded colorectal adenomas reveals the heterogeneous nature of traditional serrated adenomas compared to other colorectal adenomas. J Pathol 250(3):251–261. (PMID: 3172902810.1002/path.5366) ; Galamb O, Kalmár A, Barták BK, Patai AV, Leiszter K, Péterfia B, Wichmann B, Valcz G, Veres G, Tulassay Z, Molnár B (2016) Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma. World J Gastroenterol 22(47):10325–10340. (PMID: 28058013517524510.3748/wjg.v22.i47.10325) ; Wu Z, Liu Z, Ge W, Shou J, You L, Pan H, Han W (2018) Analysis of potential genes and pathways associated with the colorectal normal mucosa-adenoma-carcinoma sequence. Cancer Med 7(6):2555–2566. (PMID: 29659199601071310.1002/cam4.1484) ; Bujko M, Kober P, Mikula M, Ligaj M, Ostrowski J, Siedlecki JA (2015) Expression changes of cell-cell adhesion-related genes in colorectal tumors. Oncol Lett 9(6):2463–2470. (PMID: 26137091447352310.3892/ol.2015.3107) ; Chu CM, Yao CT, Chang YT, Chou HL, Chou YC, Chen KH, Terng HJ, Huang CS, Lee CC, Su SL, Liu YL, Lin FG, Wetter T, Chang CW (2014) Gene expression profiling of colorectal tumors and normal mucosa by microarrays meta-analysis using prediction analysis of microarray, artificial neural network, class classification, and regression trees. Dis Markers 2014:634123. (PMID: 24959000405524610.1155/2014/634123) ; Pan F, Li M, Chen W (2018) FOXD1 predicts prognosis of colorectal cancer patients and promotes colorectal cancer progression via the ERK 1/2 pathway. Am J Transl Res 10(5):1522–1530. (PMID: 298879655992558) ; Palaniappan A, Ramar K, Ramalingam S (2016) Computational identification of novel stage-specific biomarkers in colorectal cancer progression. PLoS ONE 11(5):e0156665. (PMID: 27243824488705910.1371/journal.pone.0156665) ; Gong B, Kao Y, Zhang C, Sun F, Gong Z, Chen J (2020) Identification of hub genes related to carcinogenesis and prognosis in colorectal cancer based on integrated bioinformatics. Mediators Inflamm 2020:5934821. (PMID: 323513227171686) ; Tsukui Y, Yamaguchi T, Maekawa S, Takano S, Sato T, Enomoto N (2019) Dickkopf-4 gene expression is associated with differentiation and lymph node metastasis in colorectal cancer. JGH Open 3(5):409–416. (PMID: 31633047678837710.1002/jgh3.12177) ; El Halabi I, Bejjany R, Nasr R, Mukherji D, Temraz S, Nassar FJ, El Darsa H, Shamseddine A (2018) Ascorbic acid in colon cancer: from the basic to the clinical applications. Int J Mol Sci 19(9):2752. (PMID: 616473010.3390/ijms19092752) ; Terranova-Barberio M, Pecori B, Roca MS et al (2017) Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer: critical role of p53. J Exp C 36(1):1–13. ; Katsidzira L, Ocvirk S, Wilson A, Li J, Mahachi CB, Soni D, DeLany J, Nicholson JK, Zoetendal EG, O’Keefe SJD (2019) Differences in fecal gut microbiota, short-chain fatty acids and bile acids link colorectal cancer risk to dietary changes associated with urbanization among Zimbabweans. Nutr Cancer 71(8):1313–1324. (PMID: 3100707510.1080/01635581.2019.1602659) ; Ala U (2021) Competing endogenous RNAs and cancer: how coding and non-coding molecules cross-talk can impinge on disease. Int J Biochem Cell Biol 130:105874. (PMID: 3322739510.1016/j.biocel.2020.105874) ; Braga EA, Fridman MV, Moscovtsev AA, Filippova EA, Dmitriev AA, Kushlinskii NE (2020) LncRNAs in ovarian cancer progression, metastasis, and main pathways: ceRNA and alternative mechanisms. Int J Mol Sci 21(22):8855. (PMID: 770043110.3390/ijms21228855) ; Liu K, Yao H, Wen Y, Zhao H, Zhou N, Lei S (1864) Xiong L (2018) Functional role of a long non-coding RNA LIFR-AS1/miR-29a/TNFAIP3 axis in colorectal cancer resistance to pohotodynamic therapy. Biochim Biophys Acta Mol Basis Dis 1864(9 Pt B):2871–2880. ; Liu B, Liu Y, Zhou M, Yao S, Bian Z, Liu D, Fei B, Yin Y, Huang Z (2020) Comprehensive ceRNA network analysis and experimental studies identify an IGF2-AS/miR-150/IGF2 regulatory axis in colorectal cancer. Pathol Res Pract 216(10):153104. (PMID: 3285394410.1016/j.prp.2020.153104) ; Liu J, Li H, Zheng B, Sun L, Yuan Y, Xing C (2019) Competitive endogenous RNA (ceRNA) regulation network of lncRNA-miRNA-mRNA in colorectal carcinogenesis. Dig Dis Sci 64(7):1868–1877. (PMID: 3073423910.1007/s10620-019-05506-9) ; Sun Y, Cao B, Zhou J (2020) Roles of DANCR/microRNA-518a-3p/MDMA ceRNA network in the growth and malignant behaviors of colon cancer cells. BMC Cancer 20(1):1–13. (PMID: 10.1186/s12885-019-6169-0) ; Lei R, Feng L, Hong D (2020) ELFN1-AS1 accelerates the proliferation and migration of colorectal cancer via regulation of miR-4644/TRIM44 axis. Cancer Biomark 27(4):433–443. (PMID: 3192914110.3233/CBM-190559) ; Liu S, An G, Cao Q, Li T, Jia X, Lei L (2021) The miR-106b/NR2F2-AS1/PLEKHO2 axis regulates migration and invasion of colorectal cancer through the MAPK pathway. Int J Mol Sci 22(11):5877. (PMID: 34070923819840410.3390/ijms22115877) ; Gao SJ, Ren SN, Liu YT, Yan HW, Chen XB (2021) Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-hexokinase 2 axis. Mol Ther Oncolytics 23:14–25. (PMID: 34589581845531310.1016/j.omto.2021.06.012) ; Li W, Yu W, Jiang X, Gao X, Wang G, Jin X, Zhao Z, Liu Y (2020) The construction and comprehensive prognostic analysis of the LncRNA-associated competitive endogenous RNAs network in colorectal cancer. Front Genet 11:583. (PMID: 32714366734433110.3389/fgene.2020.00583) ; Yin TF, Zhao DY, Zhou YC, Wang QQ, Yao SK (2021) Identification of the circRNA-miRNA-mRNA regulatory network and its prognostic effect in colorectal cancer. World J Clin Cases 9(18):4520–4541. (PMID: 34222420822382410.12998/wjcc.v9.i18.4520) ; Hui Z, Zhanwei W, Xi Y, Jin L, Jing Z, Shuwen H (2020) Construction of ceRNA coexpression network and screening of molecular targets in colorectal cancer. Dis Markers 2020:2860582. (PMID: 32377269719137110.1155/2020/2860582) ; Guo L, Yang G, Kang Y, Li S, Duan R, Shen L, Jiang W, Qian B, Yin Z, Liang T (2020) Construction and analysis of a ceRNA network reveals potential prognostic markers in colorectal cancer. Front Genet 11:418. (PMID: 32457800722800510.3389/fgene.2020.00418) ; Hu D, Zhang B, Yu M, Shi W, Zhang L (2020) Identification of prognostic biomarkers and drug target prediction for colon cancer according to a competitive endogenous RNA network. Mol Med Rep 22(2):620–632. (PMID: 32468035733980310.3892/mmr.2020.11171) ; Qi X, Lin Y, Liu X, Chen J, Shen B (2020) Biomarker discovery for the carcinogenic heterogeneity between colon and rectal cancers based on lncRNA-associated ceRNA network analysis. Front Oncol 10:535985. (PMID: 33194594766268910.3389/fonc.2020.535985) ; Qian W, Feng Y, Li J, Peng W, Gu Q, Zhang Z, Ji D, Wang Q, Zhang D, Sun Y (2019) Construction of ceRNA networks reveals differences between distal and proximal colon cancers. Oncol Rep 41(5):3027–3040. (PMID: 30896838) ; Vieira LM, Jorge NAN, de Sousa JB, Setubal JC, Stadler PF, Walter MEMT (2021) Competing endogenous RNA in colorectal cancer: an analysis for colon, rectum, and rectosigmoid junction. Front Oncol 11:681579. (PMID: 34178670822281510.3389/fonc.2021.681579)
- Contributed Indexing: Keywords: Classification; Colorectal cancer; Druggable gene; Gene expression; Machine-learning; Tumor location
- Entry Date(s): Date Created: 20220810 Date Completed: 20220913 Latest Revision: 20220913
- Update Code: 20231215
|
